Explain how TPMT testing can be used to individualize therapy with thiopurines in inflammatory bowel disease (IBD)
Evaluate the role of therapeutic drug monitoring and laboratory testing (e.g., CBC) to guide dosing and assess for toxicity with thiopurines for IBD
Assess the limitations and strengths of the evidence that therapeutic drug monitoring can guide the optimization of anti-TNF therapy
Describe how to optimize the use measurement of anti-drug antibody levels and serum drug levels to guide management of patients currently receiving anti-TNF therapy
Provide appropriate care and counsel for patients and their families.